Cornerstone Advisors, LLC Gilead Sciences, Inc. Transaction History

Cornerstone Advisors, LLC

$2.51 Billion
Q3 2024

A detailed history of Cornerstone Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 68,400 shares of GILD stock, worth $6.43 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

68,400

Previous 64,500 6.05%

Holding current value

$6.43 Million

Previous $4.43 Million 29.56%

% of portfolio

0.23%

Previous 0.18%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $259,701 - $327,561	3,900 Added 6.05%	68,400 $5.73 Million
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $31,575 - $36,440	-500 Reduced 0.77%	64,500 $4.43 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $93,054 - $113,477	1,300 Added 2.04%	65,000 $4.76 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $1.72 Million - $1.95 Million	-23,500 Reduced 26.95%	63,700 $5.16 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $3.32 Million - $3.62 Million	-44,900 Reduced 33.99%	87,200 $6.53 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $2.5 Million - $2.85 Million	-32,900 Reduced 19.94%	132,100 $10.2 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $3.48 Million - $3.96 Million	45,000 Added 37.5%	165,000 $13.7 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.56 Million - $2.24 Million	-25,000 Reduced 17.24%	120,000 $10.3 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $1.49 Million - $1.7 Million	25,000 Added 20.83%	145,000 $8.95 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $6.93 Million - $7.8 Million	120,000 New	120,000 $7.42 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $5.64 Million - $6.44 Million	-94,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $3.62 Million - $4.2 Million	50,000 Added 113.64%	94,000 $7.23 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $2.76 Million - $3.53 Million	44,000 New	44,000 $3.29 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Gilead Sciences, Inc. Transaction History